AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 44 filers reported holding AERPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $551,000 | +65.0% | 326,403 | +26.0% | 0.00% | – |
| Q1 2021 | $334,000 | +125.7% | 258,974 | +70.6% | 0.00% | – |
| Q4 2020 | $148,000 | -19.1% | 151,838 | +24.2% | 0.00% | – |
| Q3 2020 | $183,000 | +28.0% | 122,243 | +6.4% | 0.00% | – |
| Q2 2020 | $143,000 | +127.0% | 114,900 | 0.0% | 0.00% | – |
| Q1 2020 | $63,000 | -55.6% | 114,900 | -50.0% | 0.00% | – |
| Q4 2019 | $142,000 | +84.4% | 229,800 | +100.0% | 0.00% | – |
| Q3 2019 | $77,000 | -26.0% | 114,900 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +1.0% | 114,900 | 0.0% | 0.00% | – |
| Q1 2019 | $103,000 | – | 114,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 5,621,835 | $9,501,000 | 5.16% |
| ABG Innovation Capital Partners III GP Ltd | 400,000 | $676,000 | 2.26% |
| Ikarian Capital, LLC | 1,676,093 | $2,832,000 | 0.23% |
| Avoro Capital Advisors LLC | 4,500,000 | $7,605,000 | 0.13% |
| Parkman Healthcare Partners LLC | 353,957 | $598,000 | 0.13% |
| Orbimed Advisors | 5,193,946 | $8,778,000 | 0.09% |
| RA Capital Management | 2,693,309 | $4,552,000 | 0.07% |
| Atom Investors LP | 79,996 | $135,000 | 0.02% |
| NEVILLE RODIE & SHAW INC | 100,000 | $169,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 208,674 | $353,000 | 0.01% |